John Rex

Impact of PASTEUR: 9.9m lives saved, ROI of 125:1

Impact of PASTEUR: 9.9m lives saved, ROI of 125:1 Dear All (and with thanks to Kevin Outterson for being lead author on this newsletter), (wonkish alert on this one … refresh your coffee and dig in!) The Center for Global Development have released a blog post and a paper estimating the potential impact of the PASTEUR Act.

Read More »

Five FDA RFPs! Antifungal animal models, MIC breakpoints, and more!

Dear All, I just today learned that FDA have posted their FY 2023 funding opportunities. All the details are on this webpage and I’m just going to reproduce the text below my signature for your reference. I’ll also add a few details in italics. Lots of good opportunities here! –jr John H. Rex, MD |

Read More »

WAAW! Must-Read Article, A Quiz, A Video, A Call to Action

Notes: Newsflash … BARDA have opened their long-running BAA-18-100-SOL-00003 to include support for antifungal agents. Search for “antifungal” in the posted .pdf to find the text. The first deadline for proposals is 15 Dec 2022 and further deadlines will doubtless follow: as shown on page 9, this BAA has offered 4 deadlines/year since 2018!  Dear All, In

Read More »

Fireside Chat with AMR Action Fund CIO Martin Heidecker

Dear All, Ahead of World Antimicrobial Awareness Week, I sat down with AMR Action Fund Chief Investment Officer Martin Heidecker for a Fireside Chat. It was a fabulous conversation that covered everything from how the Fund’s investment process works to what it’s looking for in portfolio companies to broader investment trends in the AMR space.  As

Read More »

Pull! Excellent 4-part OHE blog + BEAM support for TEE-based Pull

Dear All, Today we have several useful papers to share. First, OHE (Office of Health Economics, London) have posted a 4-part blog series that provides a succinct summary of the broken economics of antibiotics. The titles are good guides to content: Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment

Read More »

WHO releases its Fungal Priority Pathogen List (PPL)!

Dear All, Based on a 2020 RFP, we’ve known that WHO was building a fungal priority pathogen list (PPL). Well, now the list has been released. Here’s what you need to understand the new PPL: Webpage where you can get the report My PowerPoint .pptx that summarizes all the PPLs to date My webpage that provides

Read More »

Can You Answer A 3-Question Survey About This Newsletter?

Dear All, Wellcome Trust has renewed their support of AMR.Solutions and, with that, I’d like to share with you a survey about this newsletter. There are 3 questions and an optional comment box for you to write any additional thoughts you may have about this newsletter. I personally found last year’s survey to be highly

Read More »

Encouraging progress on PASTEUR!

Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), Exciting and intriguing news to share about PASTEUR (and see this 16 June 2021 newsletter if you need a refresher on the ideas behind PASTEUR)! A new draft is now circulating with the intent of attaching it to a larger bill that is on track

Read More »

CARB-X funding rounds! / The Mold That Changed The World at IDWeek!

Please note that a very interesting Quality Improvement RFP has been added to the current funding opportunities listing with an application cut-off of 6 Oct … apologies for the late posting!  Dear All, First up, CARB-X has at long last announced new funding rounds! As you’ll recall, CARB-X was recently funded for another 10 years by BARDA and Wellcome

Read More »
Scroll to Top